The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

BACKGROUND AND AIM: Transient elastography and fibrosis-4 index (FIB-4) have been proposed to access hepatic fibrosis and steatosis for patients with chronic liver disease. This study was to determine the changes of liver stiffness (LS), controlled attenuation parameter (CAP) value and FIB-4 and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yu-Chi, Hu, Tsung-Hui, Hung, Chao-Hung, Lu, Sheng-Nan, Chen, Chien-Hung, Wang, Jing-Houng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445421/
https://www.ncbi.nlm.nih.gov/pubmed/30939158
http://dx.doi.org/10.1371/journal.pone.0214323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445421/
https://www.ncbi.nlm.nih.gov/pubmed/30939158
http://dx.doi.org/10.1371/journal.pone.0214323

Ejemplares similares